Articles by James Calloway
JPMorgan Faces Internal Pushback Over Full-Time Office Mandate
JPMorgan Chase employees warn that resisting CEO Jamie Dimon's five-day office requirement could harm careers, as a petition for hybrid work gains limited traction.
Masco Surges on Strong Earnings, $2B Buyback, and Upbeat 2026 Forecast
Masco shares rallied sharply after the company exceeded quarterly profit expectations, announced a major share repurchase program, and provided guidance for 2026. The stock's gains outpaced several peers in early trading.
AppLovin Shares Extend Rally After Critic Backtracks, Earnings Loom
AppLovin stock climbed another 3% Tuesday, building on a 13% surge after CapitalWatch retracted some allegations. Investors now await quarterly results due Wednesday.
Meta Faces EU Pressure Over WhatsApp AI Access, Stock Dips Slightly
Meta shares edged lower as EU regulators consider forcing WhatsApp to open its business platform to rival AI assistants. Separately, WhatsApp won a court ruling to challenge a €225 million privacy fine.
Ferrari Shares Surge on Strong Q4 Results and Updated EV Strategy
Ferrari's stock climbed nearly 9% after the luxury automaker exceeded fourth-quarter expectations and provided an update on its first electric vehicle, the Luce.
Marriott Shares Surge on 2026 Outlook Despite Mixed Travel Demand
Marriott International stock jumped over 9% after reporting quarterly results and issuing 2026 guidance, highlighting a divergence between strong luxury demand and softer budget travel.
S&P Global Tumbles on Subpar 2026 Forecast, Drags Down Financial Data Peers
S&P Global shares fell sharply after issuing a 2026 profit outlook below analyst expectations, sparking a sell-off in related financial information stocks.
Philips Soars on Upgraded Margin Targets and Dividend Plan
Philips shares surged over 11% after the company projected stronger profitability through 2026, including an adjusted EBITA margin of 12.5%-13.0% and free cash flow up to €1.5 billion.
Kenvue Shares Steady Ahead of Q4 Report, Merger Timeline in Focus
Kenvue stock held near $18 in premarket trading as investors await fourth-quarter results on Feb. 17, with no earnings call scheduled due to the pending Kimberly-Clark merger.
Hims & Hers Stock Extends Slide Amid Weight-Loss Pill Halt, Regulatory Pressure
Hims & Hers Health shares fell another 4.2% premarket Tuesday, compounding a 16% drop Monday, after discontinuing its compounded semaglutide pill. The company faces a patent lawsuit from Novo Nordisk and potential FDA action.
Jumia Shares Slip on Q4 Revenue Miss, Unveils 2026 Targets and Algeria Exit
Jumia's stock fell premarket after reporting Q4 revenue of $61.4M, below estimates. The company outlined 2026 GMV growth targets and plans to exit Algeria in Q1.
Fiserv Shares Gain on Q4 Earnings Beat, Outlook Points to 2026 as Pivotal Year
Fiserv stock advanced in premarket trading after the payments processor reported quarterly profit above estimates and issued guidance for 2026. The company is navigating a strategic reset following a challenging prior year.